CANDACE SHIREMAN: Open Payments
NPI 1104374966 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,409 in 118 payments from 25 companies in 2025. Trend: 2023 $192 · 2024 $1,226 · 2025 $2,409
Food & beverage: $2,409
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $574 |
| AstraZeneca Pharmaceuticals LP | 7 | $379 |
| Otsuka America Pharmaceutical, Inc. | 11 | $211 |
| PFIZER INC. | 12 | $175 |
| Novo Nordisk Inc | 12 | $151 |
| Exact Sciences Corporation | 5 | $113 |
| Lilly USA, LLC | 5 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $87 |
| Lundbeck LLC | 3 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $68 |
Products named: VRAYLAR, REXULTI, BREZTRI, UBRELVY, AIRSUPRA, Cologuard Collection Kit, NURTEC ODT, JARDIANCE.
Industry payments across KY — which companies pay providers there.
